2018-2023 Global RNAi for Therapeutic Market Report

2018-2023 Global RNAi for Therapeutic Market Report

Category

Medical Devices

Published Date

9th Jun 2018

Pages

136

Choose License

Final Price

This report covers the present scenario (with the base year being 2017) and the growth prospects of global RNAi for Therapeutic market for 2018-2023.

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
RNAi for Therapeutic is in the development stage and there is no use in the market. The fastest research is Clinical phrase III, Such as QP1-1007, QO1-1002 of Quark Pharmaceuticals. The major technology of RNAi for Therapeutic is siRNA, miRNA and shRNA. SiRNA technology is the most popular, with the expenses market share of 85%, following SiRNA, miRNA is the second of 16% expenses market share in 2015.
At present, global expenses concentrates in US and Europe, US takes 80% market share and Europe takes 5% market share. There is A Few R & D Company in the world and the market concentration is high. The top5 (expenses in RNAi for Therapeutic) companies are Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Gradalis, miRagen Therapeutics. The five companies occupy about 83% of the market share.
Over the next five years, this report projects that RNAi for Therapeutic will register a 24.0% CAGR in terms of revenue, reach US$ 3580 million by 2023, from US$ 990 million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of RNAi for Therapeutic market by product type, application, key companies and key regions.

To calculate the market size, this report considers value generated from the sales of the following segments:

Segmentation by product type:
siRNA
miRNA
Segmentation by application:
Cancer
Cardiovascular
HBV
Other

We can also provide the customized separate regional or country-level reports, for the following regions:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global RNAi for Therapeutic market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of RNAi for Therapeutic market by identifying its various subsegments.
Focuses on the key global RNAi for Therapeutic players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the RNAi for Therapeutic with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of RNAi for Therapeutic submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global RNAi for Therapeutic Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global RNAi for Therapeutic Market Size 2013-2023
2.1.2 RNAi for Therapeutic Market Size CAGR by Region
2.2 RNAi for Therapeutic Segment by Type
2.2.1 siRNA
2.2.2 miRNA
2.2.3 shRNA
2.3 RNAi for Therapeutic Market Size by Type
2.3.1 Global RNAi for Therapeutic Market Size Market Share by Type (2013-2018)
2.3.2 Global RNAi for Therapeutic Market Size Growth Rate by Type (2013-2018)
2.4 RNAi for Therapeutic Segment by Application
2.4.1 Cancer
2.4.2 Cardiovascular
2.4.3 HBV
2.4.4 Other
2.5 RNAi for Therapeutic Market Size by Application
2.5.1 Global RNAi for Therapeutic Market Size Market Share by Application (2013-2018)
2.5.2 Global RNAi for Therapeutic Market Size Growth Rate by Application (2013-2018)

3 Global RNAi for Therapeutic by Players
3.1 Global RNAi for Therapeutic Market Size Market Share by Players
3.1.1 Global RNAi for Therapeutic Market Size by Players (2016-2018)
3.1.2 Global RNAi for Therapeutic Market Size Market Share by Players (2016-2018)
3.2 Global RNAi for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAi for Therapeutic by Regions
4.1 RNAi for Therapeutic Market Size by Regions
4.2 Americas RNAi for Therapeutic Market Size Growth
4.3 APAC RNAi for Therapeutic Market Size Growth
4.4 Europe RNAi for Therapeutic Market Size Growth
4.5 Middle East & Africa RNAi for Therapeutic Market Size Growth

5 Americas
5.1 Americas RNAi for Therapeutic Market Size by Countries
5.2 Americas RNAi for Therapeutic Market Size by Type
5.3 Americas RNAi for Therapeutic Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC RNAi for Therapeutic Market Size by Countries
6.2 APAC RNAi for Therapeutic Market Size by Type
6.3 APAC RNAi for Therapeutic Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe RNAi for Therapeutic by Countries
7.2 Europe RNAi for Therapeutic Market Size by Type
7.3 Europe RNAi for Therapeutic Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa RNAi for Therapeutic by Countries
8.2 Middle East & Africa RNAi for Therapeutic Market Size by Type
8.3 Middle East & Africa RNAi for Therapeutic Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global RNAi for Therapeutic Market Forecast
10.1 Global RNAi for Therapeutic Market Size Forecast (2018-2023)
10.2 Global RNAi for Therapeutic Forecast by Regions
10.2.1 Global RNAi for Therapeutic Forecast by Regions (2018-2023)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global RNAi for Therapeutic Forecast by Type
10.8 Global RNAi for Therapeutic Forecast by Application

11 Key Players Analysis
11.1 Alnylam Pharmaceuticals
11.1.1 Company Details
11.1.2 RNAi for Therapeutic Product Offered
11.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.1.4 Main Business Overview
11.1.5 Alnylam Pharmaceuticals News
11.2 Arbutus Biopharma (Tekmira)
11.2.1 Company Details
11.2.2 RNAi for Therapeutic Product Offered
11.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.2.4 Main Business Overview
11.2.5 Arbutus Biopharma (Tekmira) News
11.3 Arrowhead
11.3.1 Company Details
11.3.2 RNAi for Therapeutic Product Offered
11.3.3 Arrowhead RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.3.4 Main Business Overview
11.3.5 Arrowhead News
11.4 Dicerna Pharmaceuticals
11.4.1 Company Details
11.4.2 RNAi for Therapeutic Product Offered
11.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.4.4 Main Business Overview
11.4.5 Dicerna Pharmaceuticals News
11.5 Mirna Therapeutics
11.5.1 Company Details
11.5.2 RNAi for Therapeutic Product Offered
11.5.3 Mirna Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.5.4 Main Business Overview
11.5.5 Mirna Therapeutics News
11.6 Quark Pharmaceuticals
11.6.1 Company Details
11.6.2 RNAi for Therapeutic Product Offered
11.6.3 Quark Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.6.4 Main Business Overview
11.6.5 Quark Pharmaceuticals News
11.7 RXi Pharmaceuticals
11.7.1 Company Details
11.7.2 RNAi for Therapeutic Product Offered
11.7.3 RXi Pharmaceuticals RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.7.4 Main Business Overview
11.7.5 RXi Pharmaceuticals News
11.8 Silence Therapeutics
11.8.1 Company Details
11.8.2 RNAi for Therapeutic Product Offered
11.8.3 Silence Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.8.4 Main Business Overview
11.8.5 Silence Therapeutics News
11.9 Benitec Biopharma
11.9.1 Company Details
11.9.2 RNAi for Therapeutic Product Offered
11.9.3 Benitec Biopharma RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.9.4 Main Business Overview
11.9.5 Benitec Biopharma News
11.10 miRagen Therapeutics
11.10.1 Company Details
11.10.2 RNAi for Therapeutic Product Offered
11.10.3 miRagen Therapeutics RNAi for Therapeutic Revenue, Gross Margin and Market Share (2016-2018)
11.10.4 Main Business Overview
11.10.5 miRagen Therapeutics News
11.11 Sylentis
11.12 Gradalis
11.13 Sirnaomics
11.14 Silenseed

12 Research Findings and Conclusion
List of Tables and Figures_x000D_
_x000D_
Table Product Specifications of RNAi for Therapeutic_x000D_
Figure RNAi for Therapeutic Report Years Considered_x000D_
Figure Market Research Methodology_x000D_
Figure Global RNAi for Therapeutic Market Size Growth Rate 2013-2023 ($ Millions)_x000D_
Table RNAi for Therapeutic Market Size CAGR by Region 2013-2023 ($ Millions)_x000D_
Table Major Players of siRNA_x000D_
Table Major Players of miRNA_x000D_
Table Major Players of shRNA_x000D_
Table Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Market Share by Type (2013-2018)_x000D_
Figure Global RNAi for Therapeutic Market Size Market Share by Type (2013-2018)_x000D_
Figure Global siRNA Market Size Growth Rate_x000D_
Figure Global miRNA Market Size Growth Rate_x000D_
Figure Global shRNA Market Size Growth Rate_x000D_
Figure RNAi for Therapeutic Consumed in Cancer_x000D_
Figure Global RNAi for Therapeutic Market: Cancer (2013-2018) ($ Millions)_x000D_
Figure Global Cancer YoY Growth ($ Millions)_x000D_
Figure RNAi for Therapeutic Consumed in Cardiovascular_x000D_
Figure Global RNAi for Therapeutic Market: Cardiovascular (2013-2018) ($ Millions)_x000D_
Figure Global Cardiovascular YoY Growth ($ Millions)_x000D_
Figure RNAi for Therapeutic Consumed in HBV_x000D_
Figure Global RNAi for Therapeutic Market: HBV (2013-2018) ($ Millions)_x000D_
Figure Global HBV YoY Growth ($ Millions)_x000D_
Figure RNAi for Therapeutic Consumed in Other_x000D_
Figure Global RNAi for Therapeutic Market: Other (2013-2018) ($ Millions)_x000D_
Figure Global Other YoY Growth ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Market Share by Application (2013-2018)_x000D_
Figure Global RNAi for Therapeutic Market Size Market Share by Application (2013-2018)_x000D_
Figure Global RNAi for Therapeutic Market Size in Cancer Growth Rate_x000D_
Figure Global RNAi for Therapeutic Market Size in Cardiovascular Growth Rate_x000D_
Figure Global RNAi for Therapeutic Market Size in HBV Growth Rate_x000D_
Figure Global RNAi for Therapeutic Market Size in Other Growth Rate_x000D_
Table Global RNAi for Therapeutic Revenue by Players (2016-2018) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Revenue Market Share by Players (2016-2018)_x000D_
Figure Global RNAi for Therapeutic Revenue Market Share by Players in 2017_x000D_
Table Global RNAi for Therapeutic Key Players Head office and Products Offered_x000D_
Table RNAi for Therapeutic Concentration Ratio (CR3, CR5 and CR10) (2016-2018)_x000D_
Table Global RNAi for Therapeutic Market Size by Regions 2013-2018 ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Market Share by Regions 2013-2018_x000D_
Figure Global RNAi for Therapeutic Market Size Market Share by Regions 2013-2018_x000D_
Figure Americas RNAi for Therapeutic Market Size 2013-2018 ($ Millions)_x000D_
Figure APAC RNAi for Therapeutic Market Size 2013-2018 ($ Millions)_x000D_
Figure Europe RNAi for Therapeutic Market Size 2013-2018 ($ Millions)_x000D_
Figure Middle East & Africa RNAi for Therapeutic Market Size 2013-2018 ($ Millions)_x000D_
Table Americas RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table Americas RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)_x000D_
Figure Americas RNAi for Therapeutic Market Size Market Share by Countries in 2017_x000D_
Table Americas RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Americas RNAi for Therapeutic Market Size Market Share by Type (2013-2018)_x000D_
Figure Americas RNAi for Therapeutic Market Size Market Share by Type in 2017_x000D_
Table Americas RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Americas RNAi for Therapeutic Market Size Market Share by Application (2013-2018)_x000D_
Figure Americas RNAi for Therapeutic Market Size Market Share by Application in 2017_x000D_
Figure United States RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Canada RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Mexico RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Table APAC RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table APAC RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)_x000D_
Figure APAC RNAi for Therapeutic Market Size Market Share by Countries in 2017_x000D_
Table APAC RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)_x000D_
Table APAC RNAi for Therapeutic Market Size Market Share by Type (2013-2018)_x000D_
Figure APAC RNAi for Therapeutic Market Size Market Share by Type in 2017_x000D_
Table APAC RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)_x000D_
Table APAC RNAi for Therapeutic Market Size Market Share by Application (2013-2018)_x000D_
Figure APAC RNAi for Therapeutic Market Size Market Share by Application in 2017_x000D_
Figure China RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Japan RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Korea RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Southeast Asia RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure India RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Australia RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Table Europe RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table Europe RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)_x000D_
Figure Europe RNAi for Therapeutic Market Size Market Share by Countries in 2017_x000D_
Table Europe RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Europe RNAi for Therapeutic Market Size Market Share by Type (2013-2018)_x000D_
Figure Europe RNAi for Therapeutic Market Size Market Share by Type in 2017_x000D_
Table Europe RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Europe RNAi for Therapeutic Market Size Market Share by Application (2013-2018)_x000D_
Figure Europe RNAi for Therapeutic Market Size Market Share by Application in 2017_x000D_
Figure Germany RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure France RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure UK RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Italy RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Russia RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Spain RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Table Middle East & Africa RNAi for Therapeutic Market Size by Countries (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Countries in 2017_x000D_
Table Middle East & Africa RNAi for Therapeutic Market Size by Type (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type (2013-2018)_x000D_
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Type in 2017_x000D_
Table Middle East & Africa RNAi for Therapeutic Market Size by Application (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application (2013-2018)_x000D_
Figure Middle East & Africa RNAi for Therapeutic Market Size Market Share by Application in 2017_x000D_
Figure Egypt RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure South Africa RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Israel RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Turkey RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure GCC Countries RNAi for Therapeutic Market Size Growth 2013-2018 ($ Millions)_x000D_
Figure Global RNAi for Therapeutic arket Size Forecast (2018-2023) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Forecast by Regions (2018-2023) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Regions_x000D_
Figure Americas RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure APAC RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Europe RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Middle East & Africa RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure United States RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Canada RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Mexico RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Brazil RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure China RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Japan RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Korea RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Southeast Asia RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure India RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Australia RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Germany RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure France RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure UK RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Italy RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Russia RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Spain RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Egypt RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure South Africa RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Israel RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure Turkey RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Figure GCC Countries RNAi for Therapeutic Market Size 2018-2023 ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Forecast by Type (2018-2023) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Type (2018-2023)_x000D_
Table Global RNAi for Therapeutic Market Size Forecast by Application (2018-2023) ($ Millions)_x000D_
Table Global RNAi for Therapeutic Market Size Market Share Forecast by Application (2018-2023)_x000D_
Table Alnylam Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Alnylam Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Arbutus Biopharma (Tekmira) Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Arbutus Biopharma (Tekmira) RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Arrowhead Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Arrowhead RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Arrowhead RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Dicerna Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Dicerna Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Mirna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Mirna Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Quark Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Quark Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table RXi Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table RXi Pharmaceuticals RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Silence Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Silence Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Silence Therapeutics RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Benitec Biopharma Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Benitec Biopharma RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure Benitec Biopharma RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table miRagen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table miRagen Therapeutics RNAi for Therapeutic Revenue and Gross Margin (2016-2018)_x000D_
Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2016-2018)_x000D_
Table Sylentis Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Gradalis Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Sirnaomics Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_
Table Silenseed Basic Information, Head Office, Major Market Areas and Its Competitors_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us